Electrophoresis Market Research Report describing the professional information and in-depth study on the current state of the world market along with competitive analysis. Electrophoresis exploring the market size, trend, revenue, and forecasts. This report is a valuable source of guidance for companies and individuals offering Industry Chain Structure, Business Strategies, and Proposals for New Project Investments.
The Global Electrophoresis Market is expected to reach the US $2.15, growing at a CAGR of 5.4% during the forecast period.
The Global Electrophoresis Market segmented on the basis of product, application, end user, and region.
The global Electrophoresis Market by an end user is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers, and other end users. In 2016, the academic & research institutes segment accounted for the largest share of the market. This can be attributed to the increased R&D spending, global rise in the number of biotechnology and life science research studies and growing public and private investments in research studies.
Objectives of the Study
Major Growth Drivers for Electrophoresis Market:
· Rising Incidence of Cancer, Infectious Diseases, and Genetic Disorders
· Growth in Funding for Research on Genomic, Proteomic, and Electrophoresis Techniques
· Growing Number of Industry-Academia Research Collaborations
· Growing Use of Capillary Electrophoresis with Mass Spectroscopy
· Growing Use of Next-Generation Sequencing
· Rapid Growth in Aging Population
North America accounted for the largest share of the Electrophoresis Market in 2016, followed by Europe and Asia-Pacific. The patent expiration of several blockbuster drugs of major pharmaceutical companies is, in turn, increasing investments for new drug discovery; this is a key market driver in North America.
Speak to Our Subject Expert:
Some of the major Key players operating in the Global Market;
The prominent players in the global Electrophoresis Market are Bio-Rad Laboratories (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Merck Millipore (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), Shimadzu Corporation (Japan), Harvard Bioscience, Inc. (U.S.), Sebia Group (U.K.), and C.B.S. Scientific Company, Inc. (U.S.).
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly